Nanozora (ozoralizumab)

Nanozora (ozoralizumab) for sale – Buy Nanozora (ozoralizumab) Online

What is Nanozora (ozoralizumab) for?

Nanozora (ozoralizumab) is a medicine prescribed for the treatment of rheumatoid arthritis (RA), which is inadequately managed by other treatments^[1].

Nanozora is available as a subcutaneous injection (30 mg)^[2].

How does Nanozora (ozoralizumab) work?

Nanozora’s active substance, ozoralizumab, is a novel TNF inhibitor. It targets and blocks a messenger protein known as tumor necrosis factor alpha (TNFa), which may be involved in the progression of rheumatoid arthritis (RA)^[3].

Ozoralizumab is smaller than other TNF blockers, so it can quickly reach areas of inflammation. Studies have suggested that it gets into inflamed joints more efficiently than some other medicines^[3].

Where has Nanozora (ozoralizumab) been approved?

Nanozora (ozoralizumab) is currently approved by the PMDA in Japan^[2].

References:

1. Keam, Susan J. Ozoralizumab: First Approval. PubMed, Accessed 25 September 2023.
2. Pharmaceuticals and Medical Devices Safety Information.PMDA, Accessed 25 September 2023.
3. Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor. Modern Rheumatology, 01 April 2023.